Enpatoran, a first-in-class oral small molecule toll-like receptor 7/8 inhibitor, is superior to placebo in improving mucocutaneous symptoms of cutaneous and systemic lupus, according to data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback